Abstract
The terminal N-mono- and dimethylated derivatives of an estrone–salicylaldehyde thiosemicarbazone hybrid and their highly cytotoxic Cu(II) complexes were synthesized and characterized in addition to their structurally related simpler bicyclic analogues. Solution stability and structure of the complexes were determined by UV–visible spectrophotometry and electron paramagnetic resonance spectroscopy. The monomethylation has a minor influence on the pKa values, while the dimethylation results in somewhat more acidic derivatives compared to the non-methylated derivatives, although all the compounds are neutral at physiological pH. Based on the speciation studies performed in a 30% (v/v) dimethyl sulfoxide/water mixture, the four novel ligands form fairly high-stability complexes with Cu(II) ions, in which they coordinate in mono-anionic (O‒,N,S) or di-anionic (O‒,N,S‒) binding modes. [CuLH‒1] species with (O‒,N,S‒)(H2O) coordination mode are present in solution at neutral pH, and these complexes were isolated and further studied. The Cu(II) complexes formed with the estrone hybrids were more stable in comparison with the bicyclic analogues. The terminal N-dimethylation results in the most stable complexes in a given ligand series. In vitro cytotoxicity of all the Cu(II) complexes was measured in 3D spheroids of HCT-116, A-549 and CH-1 human cancer cells which showed fairly low IC50 values (3.9‒17.1 μM). The Cu(II) complexes caused reduced tumour growth, and they activated the caspase-3 and caspase-7 endoproteases leading to apoptosis except the case of the complex formed with the monomethylated bicyclic derivative, where other type of mechanisms of action seems to induce the cell death.
Graphic abstract
Anticancer Cu(II) complexes of mono- and dimethylated salicylaldehyde thiosemicarbazone-estrone hybrids possessing high solution stability and strong cytotoxic effect against 3D spheroids of a series of human cancer cells. 398x273 mm (150 x 150 DPI)
Similar content being viewed by others
References
Kalinowski DS, Quach P, Richardson DR (2009) Future Med Chem 1:1143–1151
Heffeter P, Pape VFS, Enyedy ÉA, Keppler BK, Szakács G, Kowol CR (2019) Antioxid Redox Signal 30:1062–1082
https://clinicaltrials.gov/ct2/show/NCT02466971. Accessed on 18/05/2021
Salim KY, Vareki SM, Danter WR, Koropatnick J (2016) Oncotarget 7:41363
Guo ZL, Richardson DR, Kalinowski DS, Kovacevic Z, Tan-Un KC, Chan GCF (2016) J Hematol Oncol 9:1–16
Dilworth JR, Hueting R (2012) Inorg Chim Acta 389:3–15
West DX, Liberta AE, Padhye SB, Chikate RC, Sonawane PB, Kumbhar AS, Yerande RG (1993) Coord Chem Rev 123:49–71
Shao J, Zhou B, Di Bilio AJ, Zhu L, Wang T, Shih CQJ, Yen Y (2006) Mol Cancer Ther 5:586–592
Park KC, Fouani L, Jansson PJ, Wooi D, Sahni S, Lane DJR, Palanimuthu D, Lok HC, Kovačević Z, Huang MLH, Kalinowski DS, Richardson DR (2016) Metallomics 8:874–886
Hager S, Korbula K, Bielec B, Grusch M, Pirker C, Schosserer M, Liendl L, Lang M, Grillari J, Nowikovsky K, Pape VFS, Mohr T, Szakacs G, Keppler BK, Berger W, Kowol CR, Heffeter P (2018) Cell Death Dis 9:1052
Belicchi Ferrari M, Capacchi S, Pelosi G, Reffo G, Tarasconi P, Albertini R, Pinelli S, Lunghi P (1999) Inorg Chim Acta 286:134–141
Zhang Z, Gou Y, Wang J, Yang K, Qi J, Zhou Z, Liang S, Liang H, Yang F (2016) Eur J Med Chem 121:399–409
Huang Y, Kong E, Gan C, Liu Z, Lin Q, Cui J (2015) Bioinorg Chem Appl 2015:742592
Huang Y, Kong E, Zhan J, Chen S, Gan C, Liu Z, Pang L, Cui J (2017) Bioinorg Chem Appl 2017:4276919
Heng MP, Sinniah SK, Teoh WY, Sim KS, Ng SW, Cheah YK, Wai Tan K (2015) Spectrochim Acta A Mol Biomol Spectrosc 150:360–372
Heng MP, Sim KS, Tan KW (2020) J Inorg Biochem 208:111097
Petrasheuskaya TV, Kiss MA, Dömötör O, Holczbauer T, May NV, Spengler G, Kincses A, Čipak Gašparović A, Frank É, Enyedy ÉA (2020) New J Chem 44:12154–12168
Kowol CR, Trondl R, Heffeter P, Arion VB, Jakupec MA, Roller A, Galanski M, Berger W, Keppler BK (2009) J Med Chem 52:5032–5043
Kowol CR, Miklos W, Pfaff S, Hager S, Kallus S, Pelivan K, Kubanik M, Enyedy ÉA, Berger W, Heffeter P, Keppler BK (2016) J Med Chem 59:6739–6752
Hager S, Pape VFS, Pósa V, Montsch B, Uhlik L, Szakács G, Tóth S, Jabronka N, Keppler BK, Kowol CR, Enyedy ÉA, Heffeter P (2020) Antioxid Redox Signal 33:395–414
Hofsløkken NU, Skattebøl L (1999) Acta Chem Scand 53:258–262
Enyedy ÉA, Zsigó É, Nagy NV, Kowol CR, Roller A, Keppler BK, Kiss T (2012) Eur J Inorg Chem 2012:4036–4047
Majumder S, Dutta P, Mookerjee A, Choudhuri SK (2006) Chem Biol Interact 159:90–103
Jungwirth U, Kowol CR, Keppler BK, Hartinger CG, Berger W, Heffeter P (2011) Antioxid Redox Signal 15:1085–1127
Santoro A, Vileno B, Palacios O, Peris-Díaz MD, Riegel G, Gaiddon C, Krężel A, Faller P (2019) Metallomics 11:994–1004
Hickman JA, Graeser R, de Hoogt R, Vidic S, Brito C, Gutekunst M, van der Kuip H (2014) IMI PREDECT consortium. J Biotechnol 9:1115–1128
Becceneri AB, Fuzer AM, Plutin AM, Batista AA, Lelièvre SA, Cominetti MR (2020) Inorg Chem Front 7:2909–2919
Walzl A, Unger C, Kramer N, Unterleuthner D, Scherzer M, Hengstchläger M, Schwanzer-Pfeiffer D, Dolznig H (2014) J Biomol Screen 19:1047–1059
Kim SJ, Kim HS, Seo YR (2019) Oxid Med Cell Longev 2019:5381692
Denoyer D, Masaldan S, La Fontaine S, Cater MA (2015) Metallomics 7:1459–1476
Elmore S (2007) Toxicol Pathol 35:495–516
Saraste A, Pulkki K (2000) Cardiovasc Res 45:528–537
Wernitznig D, Kiakos K, Del Favero G, Harrer N, Machat H, Osswald A, Jakupec MA, Wernitznig A, Sommergruber W, Keppler BK (2019) Metallomics 11:1044–1048
Tan CP, Lu YY, Ji LN, Mao ZW (2014) Metallomics 6:978–995
Wlodkowic D, Telford W, Skommer J, Darzynkiewicz Z (2011) Method Cell Biol 103:55–98
Schutters K, Reutelingsperger C (2010) Apoptosis 15:1072–1082
Korngold EC, Jaffer FA, Weissleder R, Sosnovik DE (2008) Heart Fail Rev 13:163–173
Nagata S, Suzuki J, Segawa K, Fujii T (2016) Cell Death Diff 6:952–961
Sun X, Kaufman PD (2018) Chromosoma 127:175–186
Rockenbauer A, Korecz L (1996) Appl Magn Reson 10:29–43
Irving HM, Miles MG, Pettit LD (1967) Anal Chim Acta 38:475–488
Zékány L, Nagypál I (1985). In: Leggett DL (ed) Computational methods for the determination of stability constants. Plenum Press, New York, pp 291–353
Acknowledgements
This work was supported by National Research, Development and Innovation Office-NKFIA (Hungary) through projects FK 124240, K124544, GINOP-2.3.2-15-2016-00038, Ministry of Human Capacities (Hungary) grant TKP-2020 and the Visegrad Scholarship 52010752 (T.V.P.).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There are no conflicts to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Petrasheuskaya, T.V., Wernitznig, D., Kiss, M.A. et al. Estrone–salicylaldehyde N-methylated thiosemicarbazone hybrids and their copper complexes: solution structure, stability and anticancer activity in tumour spheroids. J Biol Inorg Chem 26, 775–791 (2021). https://doi.org/10.1007/s00775-021-01891-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-021-01891-7